Series B - Esperance Pharmaceuticals - Jun 1, 2011 Funding Round Profile - Cointime

Bitcoin $95,059.08 -1.70%
Ethereum $3,479.06 +4.27%
BNB $643.87 -1.76%
Optimism $2.36 +9.00%
Arbitrum $0.94 +13.45%
Solana $239.40 -4.20%
Polygon $0.58 +4.06%
Cosmos $8.10 -4.33%
Avalanche $42.72 +5.20%

Bitcoin $95,059.08 -1.70%
Ethereum $3,479.06 +4.27%
BNB $643.87 -1.76%
Optimism $2.36 +9.00%
Arbitrum $0.94 +13.45%
Solana $239.40 -4.20%
Polygon $0.58 +4.06%
Cosmos $8.10 -4.33%
Avalanche $42.72 +5.20%

Esperance Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 7.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Sanofi	-	Yes	-	Detail
Advantage Capital	-	-	-	Detail
Themelios Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 24, 2008	Series A	$ 3.20M	Themelios Ventures	Detail
Oct 31, 2006	Series A	$ 9M	Themelios Ventures	Detail